LDS/Medical Tests/Polycystic Kidney Disease, Autosomal Dominant (PKD1 and PKD2), Gene Analysis

Polycystic Kidney Disease, Autosomal Dominant (PKD1 and PKD2), Gene Analysis

Adult type autosomal dominant polycystic kidney disease (ADPKD) is a late-onset multisystem disorder characterized by bilateral renal cysts, cysts in other organs (liver, pancreas, seminal vesicle, arachnoid membrane) and vascular abnormalities. Hypertension, renal pain and renal insufficiency are important clinical manifestations of ADPKD. ADPKD gradually develops over several decades. Almost half of the patients with ADPKD have end-stage renal disease (ESRD) by age 60.

Mutations in PKD1 and PKD2 genes account for the majority of ADPKD cases. The polycystic kidney disease 1 (PKD1) locus (#601313) at 16p13.3 accounts for about 85% of the patients, and the polycystic kidney disease 2 (PKD2) locus (#173910) at 4q22.1 accounts for most of the remaining patients. The disease progression to ESRD is highly variable according to genetic loci. Patients with PKD1 mutations have larger kidneys and earlier onset of ESRD than those with PKD2 mutations and in most cases, show worse prognosis. Imaging of the kidneys is the primary method for diagnosis; however, molecular testing can be of value in the diagnosis of ADPKD and for evaluation of at-risk individuals with equivocal imaging results, younger at-risk individuals, and individuals with atypical or de novo cystic renal disease.

  • Diagnosis of Autosomal Dominant Adult Polycystic Kidney Disease
  • Prenatal diagnosis if there is a high suspicion of ADPKD based on ultrasound findings

Identification of previously reported a pathogenic PKD1 or PKD2 mutation in one of the alleles almost always suggests ADPKD.

A negative result does not always rule out ADPKP as some variant forms lack PKD1 or PKD2 mutations.

Negative for mutation analysis (No pathogenic mutations detected)

Bi-directional targeted sequencing by traditional (Sanger's) sequencing or Next generation sequencing (NGS), Multiplex Ligation-dependent Probe Amplification (MLPA), PCR with Allele Specific Primer Extension (ASPE) on chip array or liquid bead array (Luminex).

Whole blood in a lavender top (EDTA) tube. Buccal swabs with appropriate transport media.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
If PKD1 and PKD2 mutations are not detected and clinical suspicion remains for a pathogenic mutation concerning a family history, ADPKD III (ADPKD3) mutations can be considered. PKD3 is caused by heterozygous mutation in the GANAB gene. DNA linkage analysis is also detecting excessive consecration of the putative alleles underlying a family phenotype. Nevertheless, DNA of a minimum 4 affected family members in two generations is required.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login